361 related articles for article (PubMed ID: 26576093)
1. Management of hepatitis B virus infection after liver transplantation.
Jiménez-Pérez M; González-Grande R; Mostazo Torres J; González Arjona C; Rando-Muñoz FJ
World J Gastroenterol; 2015 Nov; 21(42):12083-90. PubMed ID: 26576093
[TBL] [Abstract][Full Text] [Related]
2. A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.
Chen G; Liu H; Hu ZQ; Bai JH; Liu QY; Zhao YP; Gan XM; Wang F; Wang DD; Ma LJ; Li L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):901-6. PubMed ID: 26011237
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in prevention of hepatitis B recurrence after liver transplantation.
Xi ZF; Xia Q
World J Gastroenterol; 2015 Jan; 21(3):829-35. PubMed ID: 25624716
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study.
Shen S; Jiang L; Xiao GQ; Yan LN; Yang JY; Wen TF; Li B; Wang WT; Xu MQ; Wei YG
World J Gastroenterol; 2015 Jan; 21(2):584-92. PubMed ID: 25593480
[TBL] [Abstract][Full Text] [Related]
5. Application of nucleoside analogues to liver transplant recipients with hepatitis B.
Song ZL; Cui YJ; Zheng WP; Teng DH; Zheng H
World J Gastroenterol; 2015 Nov; 21(42):12091-100. PubMed ID: 26576094
[TBL] [Abstract][Full Text] [Related]
6. Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation.
Ishigami M; Ogura Y; Hirooka Y; Goto H
World J Gastroenterol; 2015 Sep; 21(36):10290-8. PubMed ID: 26420956
[TBL] [Abstract][Full Text] [Related]
7. Prevention of lamivudine-resistant hepatitis B recurrence after liver transplantation with entecavir plus tenofovir combination therapy and perioperative hepatitis B immunoglobulin only.
Karlas T; Hartmann J; Weimann A; Maier M; Bartels M; Jonas S; Mössner J; Berg T; Tillmann HL; Wiegand J
Transpl Infect Dis; 2011 Jun; 13(3):299-302. PubMed ID: 21159112
[TBL] [Abstract][Full Text] [Related]
8. Short Course of Postoperative Hepatitis B Immunoglobulin Plus Antivirals Prevents Reinfection of Liver Transplant Recipients.
Radhakrishnan K; Chi A; Quan DJ; Roberts JP; Terrault NA
Transplantation; 2017 Sep; 101(9):2079-2082. PubMed ID: 28880197
[TBL] [Abstract][Full Text] [Related]
9. Oral Nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B With Preexisting rt204 Mutation.
Fung J; Wong T; Chok K; Chan A; Sin SL; Cheung TT; Dai WC; Ng K; Ng K; Man K; Seto WK; Lai CL; Yuen MF; Lo CM
Transplantation; 2017 Oct; 101(10):2391-2398. PubMed ID: 28731907
[TBL] [Abstract][Full Text] [Related]
10. Section 14. Combination of entecavir plus low-dose on-demand hepatitis B immunoglobulin is effective with very low hepatitis B recurrence after liver transplantation.
Hu TH; Chen CL; Lin CC; Wang CC; Chiu KW; Yong CC; Liu YW; Eng HL
Transplantation; 2014 Apr; 97 Suppl 8():S53-9. PubMed ID: 24849836
[TBL] [Abstract][Full Text] [Related]
11. Antiviral Combination Therapy With Low-Dose Hepatitis B Immunoglobulin for the Prevention of Hepatitis B Virus Recurrence in Liver Transplant Recipients: A Single-Center Experience.
Akcam AT; Ulku A; Rencuzogullari A; Eray IC; Okoh A; Kuran S; Dalcı K; Yalav O; Parsak CK; Sakman G; Demiryurek H
Transplant Proc; 2015 Jun; 47(5):1445-9. PubMed ID: 26093739
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome.
Ghaziani T; Sendi H; Shahraz S; Zamor P; Bonkovsky HL
World J Gastroenterol; 2014 Oct; 20(39):14142-55. PubMed ID: 25339803
[TBL] [Abstract][Full Text] [Related]
13. Management of chronic hepatitis B in severe liver disease.
Fung J; Lai CL; Yuen MF
World J Gastroenterol; 2014 Nov; 20(43):16053-61. PubMed ID: 25473157
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B prophylaxis using lamivudine and individualized low-dose hepatitis B immunoglobulin in living donor liver transplantation.
Jiang L; Yan L; Wen T; Li B; Zhao J; Yang J; Xu M; Wang W
Transplant Proc; 2013; 45(6):2326-30. PubMed ID: 23953544
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic managements of hepatitis B viral infection in liver transplantation.
Onoe T; Tahara H; Tanaka Y; Ohdan H
World J Gastroenterol; 2016 Jan; 22(1):165-75. PubMed ID: 26755868
[TBL] [Abstract][Full Text] [Related]
16. Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.
Cholongitas E; Papatheodoridis GV
World J Gastroenterol; 2013 Dec; 19(48):9189-97. PubMed ID: 24409047
[TBL] [Abstract][Full Text] [Related]
17. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation.
Cholongitas E; Vasiliadis T; Antoniadis N; Goulis I; Papanikolaou V; Akriviadis E
Transpl Infect Dis; 2012 Oct; 14(5):479-87. PubMed ID: 22624695
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of lamivudine or tenofovir plus intramuscular hepatitis B immunoglobulin in prevention of hepatitis B virus reinfection after liver transplant.
Nassiri-Toosi M; Kasraianfard A; Ahmadinejad Z; Dashti H; Moini M; Najafi A; Salimi J; Jafarian A
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():127-32. PubMed ID: 25894141
[TBL] [Abstract][Full Text] [Related]
20. Combination of lamivudine and adefovir without hepatitis B immune globulin is safe and effective prophylaxis against hepatitis B virus recurrence in hepatitis B surface antigen-positive liver transplant candidates.
Gane EJ; Patterson S; Strasser SI; McCaughan GW; Angus PW
Liver Transpl; 2013 Mar; 19(3):268-74. PubMed ID: 23447403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
